Susquehanna International Group
PMVP icon

Susquehanna International Group’s PMV Pharmaceuticals PMVP Stock Holding History

Susquehanna International Group’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.3K Buy
+37,531
New +$48.2K ﹤0.01% 12827
2026
Q1 		– Sell
-78,784
Closed -$98.5K – 13896
2025
Q4 		$98.5K Buy
78,784
+53,150
+207% +$71.2K ﹤0.01% 11461
2025
Q3 		$35.9K Sell
25,634
-19,124
-43% -$26.5K ﹤0.01% 11945
2025
Q2 		$47.4K Buy
+44,758
New +$43.9K ﹤0.01% 12127
2024
Q4 		– Sell
-44,160
Closed -$65.8K – 12986
2024
Q3 		$65.8K Sell
44,160
-42,457
-49% -$65.6K ﹤0.01% 11269
2024
Q2 		$140K Sell
86,617
-65,774
-43% -$119K ﹤0.01% 10766
2024
Q1 		$259K Buy
152,391
+131,537
+631% +$246K ﹤0.01% 10042
2023
Q4 		$64.6K Sell
20,854
-129,253
-86% -$342K ﹤0.01% 11600
2023
Q3 		$922K Sell
150,107
-11,374
-7% -$78.2K ﹤0.01% 6804
2023
Q2 		$1.01M Sell
161,481
-179,502
-53% -$941K ﹤0.01% 6650
2023
Q1 		$1.63M Buy
340,983
+279,921
+458% +$1.97M ﹤0.01% 5603
2022
Q4 		$531K Sell
61,062
-42,412
-41% -$452K ﹤0.01% 7698
2022
Q3 		$1.23M Buy
103,474
+70,621
+215% +$1.02M ﹤0.01% 6106
2022
Q2 		$468K Sell
32,853
-9,546
-23% -$139K ﹤0.01% 8433
2022
Q1 		$883K Sell
42,399
-6,170
-13% -$109K ﹤0.01% 7444
2021
Q4 		$1.12M Buy
48,569
+7,512
+18% +$182K ﹤0.01% 6991
2021
Q3 		$1.22M Buy
41,057
+28,948
+239% +$924K ﹤0.01% 7028
2021
Q2 		$414K Buy
+12,109
New +$404K ﹤0.01% 10047

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Susquehanna International Group's PMVP Position: Q2 2026 in Review

Susquehanna International Group opened a new position in PMV Pharmaceuticals (PMVP) in Q2 2026: 37,531 shares worth $50.3K. The stake represents ﹤0.01% of the portfolio and ranks #12827 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in PMVP as recently as Q4 2025.

Susquehanna International Group first reported a position in PMVP in Q2 2021 and has held it in 18 quarters since. The position peaked at $1.63M in Q1 2023. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • Susquehanna International Group held 37,531 shares of PMV Pharmaceuticals worth $50.3K as of Q2 2026.
  • PMV Pharmaceuticals was a new Susquehanna International Group position in Q2 2026.
  • PMV Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #12827 holding.
  • Susquehanna International Group first reported a position in PMV Pharmaceuticals in Q2 2021 and has held it in 18 quarters since.
  • Susquehanna International Group's PMV Pharmaceuticals position peaked at $1.63M in Q1 2023.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.